Stock·NASDAQ·Financial Services
Affirm Holdings, Inc. (AFRM)
- Market cap
- $24.52B
- Dividend yield
- None
- Street target
- $100.00median of 34 analysts
- 52-week range
- $42.10 $90.44
AFRM stock forecast today
Where AFRM stands today, and what CleaRank Financial AI makes of it.
AFRM at a glance
Affirm Holdings, Inc. (AFRM): Buy, 67/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($66.54 and $73.17).
- Earnings AFRM beat estimates in 2 of the 4 reports in our data, and the stock rose the next day every time.
- Insiders Insiders sold $192.5M and made no open-market purchases over the last 18 months.
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Affirm Holdings, Inc. (AFRM) Buy, with a model score of 67/100.
The analysts' outlook lifts the score most: 27 of 34 analysts rate it a buy and the median target is 37.6% above the price. Momentum holds it back most: the MACD line is negative. The trend is mixed: AFRM trades 0.67% below its 50-day average of $73.17 and 9.23% above its 200-day average of $66.54. Over the past year the price fell 4.93%.
Only on CleaRank
Figures we compute ourselves from AFRM's own price, earnings and insider-filing history. Tap one to see it in context.
AFRM stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $72.68 is 0.7% below the 50-day simple moving average of $73.17.Price above its 200-day average ›
The price is 9.2% above the 200-day simple moving average of $66.54.50-day average above the 200-day ›
The 50-day average ($73.17) is 10.0% above the 200-day average ($66.54), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 63% of its 52-week range, between $42.10 and $90.44.
AFRM share price
Pick a period: each tab shows how far AFRM has moved over it, to the last close.
Today's trading
Where AFRM sits inside today's range and its 52-week range.
AFRM fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 6.17 is 62.5% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $382.4M on revenue of $4.0B, a net margin of 9.6%.Beat estimates in most recent reports ›
AFRM beat the EPS estimate in 2 of the 4 reports in our data.
Key statistics
The headline figures for AFRM.
As of October 27, 2026, AFRM trades at $72.68, with a market value of $24.52B.
What the numbers say
CleaRank Financial AI's reading of AFRM's valuation, growth and risks.
On sales, AFRM is priced at 5.76 times, 51.6% above the sector median of 3.8.
The business converts sales into profit at a net margin of 9.6% and an operating margin of 12.63%. Shareholders' capital earns 45.13%, above the sector median of 13.8%, measured as return on equity. The balance sheet rounds out the picture, with debt-to-equity of 1.83.
$0.72 a share against a $0.84 estimate made the February 5, 2026 report a miss of 14.29%. Shares fell 4.02% in the next session.
The consensus EPS estimate stands at $3.85 for this fiscal year and $5.02 for next, a decline of 45.1% for the current year.
AFRM's average daily move is 3.56%; measured against the S&P 500, its beta is 3.82. The price is 19.64% below its 52-week high of $90.44. Insiders sold $192.5M over the last 18 months and bought none on the open market, though sales of this kind are often planned in advance and say less than purchases would.
AFRM against the Financial Services sector
How AFRM compares with the median Financial Services stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, AFRM trades at 6.17x, +62% versus the sector average of 3.80x.
Return vs XLF: Since May 15, 2025, AFRM has gained 40.4% against a gain of 9.0% for XLF.
Performance against XLF
AFRM and the Financial Services sector fund over the same days.
Revenue and earnings
How much AFRM sells, and how much of it becomes profit.
Revenue growth: Revenue grew 38.8% in FY2025 to $3.2B, from $2.3B a year earlier.
Profit margin: The net margin was 1.6% in FY2025, up from -22.3% the year before.
Profitable: AFRM earned $52.2M in FY2025.
Earnings reality check
Did AFRM beat what analysts expected, and how did the stock react?
Earnings record: AFRM beat the analyst estimate in 2 of the 4 reports in our data.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Feb 5, 2026after close | $0.84 | $0.72 | -14.29% | -4.02% | -16.26% |
| Nov 6, 2025after close | $0.62 | $0.61 | -1.61% | +11.61% | +10.95% |
| Aug 28, 2025after close | $0.43 | $0.53 | +23.26% | +10.59% | +9.20% |
| Feb 6, 2025after close | $0.43 | $0.76 | +76.74% | +21.81% | +28.39% |
Reports after February 5, 2026 are not yet in our data.
As of October 27, 2026, AFRM has beaten the analyst EPS estimate in 2 of the 4 reports in our data and rose in the first trading session after every one of those beats; its most recent report in our data, on February 5, 2026, came in 14.29% below the estimate and the stock moved -4.02% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AFRM AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 49.3, in neutral territory.RSI above 50 ›
An RSI of 49.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of AFRM
The score, the reasoning behind it, and what could move the price next.
Affirm Holdings, Inc. (AFRM) is showing a mixed trend. At $72.68, the stock is 0.67% below its 50-day average of $73.17, yet it sits 9.23% above its 200-day average of $66.54. The 50-day average is 9.96% above the 200-day, but the price has slipped beneath the shorter average. Across its 52-week range of $42.10 to $90.44, the price is at 63% of the range, 19.64% below the high.
Recent gains sit against a weaker longer record: the price rose 1.62% over the past month, rose 0.39% over the past three months and fell 4.93% over the past year. The 14-day RSI of 49.3 is in the neutral zone, and the MACD line is negative.
Analyst upgrade ›
Wolfe Research upgraded it to Outperform from Peer Perform on September 14, 2026.
Source: Analyst action, Wolfe Research, September 14, 2026New analyst coverage ›
Loop Capital started coverage at Buy on September 9, 2026.
Source: Analyst action, Loop Capital, September 9, 2026
Earnings miss ›
The February 5, 2026 report missed the EPS estimate by 14.29%, and the share price fell 4.02% in the first session after it.
Source: Earnings report, February 5, 2026
- The two nearest levels matter most: the 20-day EMA at $72.99 sits above the price, and the 200-day SMA at $66.54 sits below it.
- The 14-day RSI reads 49.3, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price fell 4.02% in the first session after the February 5, 2026 report.
AFRM's trend signals disagree. The price sits above its 200-day average of $66.54 but below its 50-day average of $73.17. Should the price close above the 50-day, both signals would point up; a close below the 200-day would point both down. Looking at the nearest levels, the 200-day SMA at $66.54 sits beneath the price, and the 20-day EMA at $72.99 sits just above it.
AFRM's 14-day RSI reads 49.3, which is in the neutral zone between 40 and 60.
Technical indicators
Momentum and trend for AFRM, from its daily closes.
As of October 27, 2026, with AFRM at $72.68, its 14-day RSI is 49.3 (neutral territory), its 50-day simple moving average is $73.17 and its 200-day is $66.54.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What AFRM moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, AFRM's 1-year correlation of daily returns is +0.58 with S&P 500 (SPY), +0.54 with Nasdaq 100 (QQQ), +0.33 with Bitcoin (BTC) and +0.05 with gold (XAU).
AFRM price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
27 of 34 analysts rate it a buy or strong buy, 7 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $100.00 is 37.6% above the price.More buy ratings than three months ago ›
27 of 34 rate it a buy now, against 25 of 34 three months ago.
AFRM Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 13, 2026 | Goldman Sachs | Maintains | Buy |
| Oct 6, 2026 | TD Cowen | Maintains | Buy |
| Oct 1, 2026 | Freedom Capital Markets | Maintains | Buy |
| Sep 16, 2026 | Citizens | Reiterates | Market Outperform |
| Sep 14, 2026 | Wolfe Research | Upgrade | Outperform |
| Sep 9, 2026 | Loop Capital | Initiates | Buy |
As of October 27, 2026, 34 Wall Street analysts cover AFRM: 27 rate it a buy or strong buy, 7 a hold and 0 a sell or strong sell. Their 12-month price targets range from $66.00 to $115.00. The median AFRM price target is $100.00, 37.6% above the price of $72.68.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
AFRM trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AFRM trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
AFRM moves about 3.6% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AFRM tends to move, against the market and on its own.
AFRM price history and drawdowns
AFRM's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 3.56% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 94.6%, from November 2021 to May 2023; the price is still 56.9% below that peak.Most 1-year holds ended higher ›
55% of 1-year holding periods in the last 6 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in January 2021 is now worth $7,211, against $21,752 in the S&P 500 (SPY).
AFRM Drawdowns & Recovery
As of October 27, 2026, AFRM's worst peak-to-trough fall over the period since January 2021 with dividends reinvested was -94.6% (November 2021 to May 2023); it is still 56.9% below that peak, and 55% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AFRM in January 2021 is worth now, against the same amount in the S&P 500.
Against the market: AFRM trailed the S&P 500 over this period: $7,211.12 against $21,752.
A $10,000 investment in AFRM in January 2021 would be worth about $7,211 today with dividends reinvested, compared with about $21,752 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AFRM, and which have not.
Strongest month, November: an average of +22.05%, up in 3 of 5 years.
Weakest month, February: an average of -14.91%, up in 1 of 6 years.
This month, October: has averaged +2.11%, up in 2 of 5 years. Past seasonality does not repeat on schedule.
Over the last 6 years, AFRM's strongest calendar month has been November (average +22.05%, up in 3 of 5 years) and its weakest February (average -14.91%, up in 1 of 6 years).
Average return for each calendar month over the last 6 years, from weekly closing prices with dividends included.
AFRM stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AFRM, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 6 years of price history, projects that a $10,000 investment in AFRM today could grow to about $9,957 by 2030 in the base case, with a 90th-percentile outcome near $35,869 and a 10th-percentile outcome around $2,764. Projections are statistical simulations, not guarantees.
AFRM Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $72.37 for AFRM by 2030 in the base case, from $72.68 today (1.0x over 4 years). The 10th-percentile path ends near $20.09. These are outcomes of a Monte Carlo simulation run on AFRM's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $38.25 | $72.60 | $138 | |
| 2028 | $29.30 | $72.52 | $179 | |
| 2029 | $23.88 | $72.45 | $220 | |
| 2030 | $20.09 | $72.37 | $261 |
Method: a lognormal simulation of AFRM's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
AFRM insider trading
What the people running the company have bought and sold.
AFRM insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought AFRM shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, AFRM insiders reported 34 open-market sales worth $192.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Sell | 65.6K | $5.2M |
| Oct 9, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Option | 65.6K | $1.8M |
| Sep 14, 2026 | Siphelele N Jiyane
Officer
|
Sell | 27.0K | $1.9M |
| Sep 4, 2026 | Siphelele N Jiyane
Officer
|
Sell | 25.0K | $1.8M |
| Sep 3, 2026 | Katherine Elizabeth Adkins
Officer
|
Sell | 83.3K | $6.1M |
| Sep 3, 2026 | Katherine Elizabeth Adkins
Officer
|
Option | 93.9K | $1.9M |
| Sep 2, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Sell | 21.6K | $1.6M |
| Sep 1, 2026 | Siphelele N Jiyane
Officer
|
Grant | 9.0K | - |
| Sep 1, 2026 | Michael Alan Linford
President
|
Grant | 11.7K | - |
| Sep 1, 2026 | Libor Michalek
President
|
Grant | 11.4K | - |
| Sep 1, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 12.0K | - |
| Aug 28, 2026 | Michael Alan Linford
Chief Operating Officer
|
Sell | 79.2K | $7.1M |
| Aug 28, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 79.2K | $427.0K |
| Aug 12, 2026 | Noel Bertram Watson Jr
Director
|
Sell | 2.0K | $155.7K |
| Jul 31, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Jul 31, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Jul 31, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jul 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Jul 1, 2026 | Richard Alan Galanti
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Jeremy Liew
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Jul 1, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jul 1, 2026 | Christa S. Quarles
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Jacqueline D Reses
Director
|
Grant | 655 | - |
| Jul 1, 2026 | Ryan M. Schneider
Director
|
Grant | 3.8K | - |
| Jun 26, 2026 | Michael Alan Linford
Chief Operating Officer
|
Sell | 100.0K | $8.0M |
| Jun 26, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 100.0K | $539.0K |
| Jun 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 10.6K | - |
| Jun 1, 2026 | Siphelele N Jiyane
Officer
|
Grant | 11.5K | - |
| Jun 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 11.7K | - |
| Jun 1, 2026 | Libor Michalek
President
|
Grant | 11.4K | - |
| Jun 1, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 16.4K | - |
| May 13, 2026 | Noel Bertram Watson Jr
Director
|
Sell | 2.0K | $130.0K |
| May 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| May 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| May 1, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Apr 14, 2026 | Noel Bertram Watson Jr
Director
|
Sell | 2.0K | $110.0K |
| Apr 2, 2026 | Christa S. Quarles
Director
|
Grant | 60.4K | - |
| Apr 1, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Apr 1, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Apr 1, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Feb 27, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 10.6K | - |
| Feb 27, 2026 | Siphelele N Jiyane
Officer
|
Grant | 11.5K | - |
| Feb 27, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 11.7K | - |
| Feb 27, 2026 | Libor Michalek
President
|
Grant | 11.4K | - |
| Feb 27, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 18.4K | - |
| Feb 9, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 20.0K | $980.0K |
| Jan 30, 2026 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.4K | - |
| Jan 30, 2026 | Michael Alan Linford
Chief Operating Officer
|
Option | 20.0K | $980.0K |
| Jan 30, 2026 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Jan 30, 2026 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jan 5, 2026 | Maksim Rafael Levchin
Chief Executive Officer
|
Sell | 666.7K | $53.7M |
| Jan 5, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Sell | 36.4K | $2.9M |
| Jan 5, 2026 | Maksim Rafael Levchin
Chief Executive Officer
|
Option | 666.7K | $32.7M |
| Jan 5, 2026 | Robert Warren O'Hare
Chief Financial Officer
|
Option | 36.4K | $1.0M |
| Dec 31, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Dec 31, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Dec 31, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Dec 15, 2025 | Richard Alan Galanti
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Brian D. Hughes
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Jeremy Liew
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Christa S. Quarles
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Jacqueline D Reses
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Rodriquez Manuel Sanchez
Director
|
Grant | 3.6K | - |
| Dec 15, 2025 | Noel Bertram Watson Jr
Director
|
Grant | 3.6K | - |
| Dec 3, 2025 | Robert Warren O'Hare
Chief Financial Officer
|
Sell | 8.2K | $573.2K |
| Dec 1, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 10.9K | - |
| Dec 1, 2025 | Siphelele N Jiyane
Officer
|
Grant | 11.5K | - |
| Dec 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 11.7K | - |
| Dec 1, 2025 | Libor Michalek
President
|
Grant | 11.4K | - |
| Dec 1, 2025 | Robert Warren O'Hare
Chief Financial Officer
|
Grant | 19.4K | - |
| Oct 31, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Oct 31, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Oct 31, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Oct 1, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Oct 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Oct 1, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Sep 15, 2025 | Siphelele Jiyane
Officer
|
Sell | 12.5K | $1.1M |
| Sep 5, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 77.7K | - |
| Sep 4, 2025 | Siphelele Jiyane
Officer
|
Sell | 25.5K | $2.3M |
| Sep 4, 2025 | Siphelele Jiyane
Officer
|
Option | 25.5K | $84.3K |
| Sep 2, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 31.4K | $2.6M |
| Sep 2, 2025 | Robert W O'Hare
Chief Financial Officer
|
Option | 43.1K | $737.2K |
| Aug 29, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 36.9K | $3.5M |
| Aug 29, 2025 | Siphelele Jiyane
Officer
|
Sell | 22.7K | $2.2M |
| Aug 29, 2025 | Christa S. Quarles
Director
|
Sell | 15.0K | $1.4M |
| Aug 29, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 53.6K | $861.1K |
| Aug 29, 2025 | Siphelele Jiyane
Officer
|
Grant | 11.5K | - |
| Aug 29, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 25.0K | - |
| Aug 29, 2025 | Libor Michalek
President
|
Grant | 23.6K | - |
| Aug 28, 2025 | Max R Levchin
Chief Executive Officer
|
Sell | 499.2K | $40.0M |
| Aug 28, 2025 | Max R Levchin
Chief Executive Officer
|
Option | 499.2K | $24.5M |
| Aug 22, 2025 | Michael Alan Linford
Chief Operating Officer
|
Sell | 184.2K | $14.8M |
| Aug 22, 2025 | Max R Levchin
Chief Executive Officer
|
Sell | 167.4K | $13.4M |
| Aug 22, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 77.8K | $6.2M |
| Aug 22, 2025 | Max R Levchin
Chief Executive Officer
|
Option | 167.4K | $8.2M |
| Aug 22, 2025 | Michael Alan Linford
Chief Operating Officer
|
Option | 184.2K | $992.8K |
| Aug 22, 2025 | Robert W O'Hare
Chief Financial Officer
|
Option | 77.8K | $2.5M |
| Aug 18, 2025 | Max R Levchin
Chief Executive Officer
|
Sell | 15.0K | $1.2M |
| Aug 18, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 11.4K | $912.4K |
| Aug 18, 2025 | Michael Alan Linford
Chief Operating Officer
|
Sell | 10.8K | $864.0K |
| Aug 18, 2025 | Max R Levchin
Chief Executive Officer
|
Option | 15.0K | $732.7K |
| Aug 18, 2025 | Michael Alan Linford
Chief Operating Officer
|
Option | 10.8K | $58.2K |
| Aug 18, 2025 | Robert W O'Hare
Chief Financial Officer
|
Option | 11.4K | $567.4K |
| Aug 6, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 6.5K | $486.7K |
| Aug 6, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 6.5K | $151.4K |
| Aug 5, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 60.6K | $4.5M |
| Aug 5, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 62.3K | $1.4M |
| Aug 4, 2025 | Siphelele Jiyane
Officer
|
Sell | 15.9K | $1.2M |
| Aug 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 2.3K | - |
| Aug 1, 2025 | Libor Michalek
President
|
Grant | 2.3K | - |
| Jul 7, 2025 | Katherine Elizabeth Adkins
Officer
|
Sell | 57.1K | $4.0M |
| Jul 7, 2025 | Robert W O'Hare
Chief Financial Officer
|
Sell | 19.8K | $1.4M |
| Jul 7, 2025 | Katherine Elizabeth Adkins
Officer
|
Option | 57.1K | $895.4K |
| Jul 1, 2025 | Christa S. Quarles
Director
|
Sell | 754 | $50.8K |
| Jul 1, 2025 | Katherine Elizabeth Adkins
Officer
|
Grant | 1.7K | - |
| Jul 1, 2025 | Richard Alan Galanti
Director
|
Grant | 8.1K | - |
| Jul 1, 2025 | Jeremy Liew
Director
|
Grant | 670 | - |
| Jul 1, 2025 | Michael Alan Linford
Chief Operating Officer
|
Grant | 8.9K | - |
| Jul 1, 2025 | Libor Michalek
President
|
Grant | 10.8K | - |
Source: TwelveData, from SEC Form 4 filings
AFRM stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.